The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?

Matti Aapro*, Michelino De Laurentiis, Daniel Rea, Juan Enrique Bargallo Rocha, Roberto Elizalde, László Landherr, Barbro Linderholm, Eleftherios Mamounas, Christos Markopoulos, Patrick Neven, Alexander Petrovsky, Roman Rouzier, Vincent Smit, Christer Svedman, Daniel Schneider, Christoph Thomssen, Miguel Martin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
281 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?'. Together they form a unique fingerprint.

Medicine & Life Sciences